Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Avant BrandsTSX:AVNT +3.33%31 Earnings per Share (Diluted) is C$-0.96 as of May. 2026. GuruFocus rates TSX:AVNT with a GF Score™ of 31/100 and a GF Value™ of C$0.95 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 786 Drug Manufacturers companies, Avant Brands ranks better than 64.76% on this metric.
Avant Brands's EPS (Basic) for the
three
months ended in May. 2026 was C$-0.24.
Its EPS (Basic) for the trailing twelve months (TTM) ended in May. 2026 was C$-0.96.
Avant Brands's EPS without NRI for the
three
months ended in May. 2026 was C$-0.21.
Its EPS without NRI for the trailing twelve months (TTM) ended in May. 2026 was C$-0.83.
During the past 3 years, the average EPS without NRIGrowth Rate was 18.50% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -0.40% per year.
During the past 13 years, Avant Brands's highest 3-Year average EPS without NRI Growth Rate was 39.80% per year. The lowest was -20.70% per year. And the median was 21.50% per year.
Avant Brands (TSX:AVNT) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Avant Brands Earnings per Share (Diluted) Related Terms
Avant Brands Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Avant Brands's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSX:AVNT vs ZTS: Earnings per Share (Diluted) Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Avant Brands's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avant Brands PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Avant Brands's PE Ratio distribution charts can be found below:
* The bar in red indicates where Avant Brands's PE Ratio falls into.
Avant Brands Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Avant Brands's Earnings Per Share (Diluted) for the fiscal year that ended in Nov. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.96
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of C$-0.96 mean?
Avant Brands (TSX:AVNT) has a Earnings per Share (Diluted) of C$-0.96 as of May. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Avant Brands and its competitors. According to the industry distribution chart, Avant Brands ranks #277 out of 786 companies in the Drug Manufacturers industry, placing it in the top 35.2%.
Is Avant Brands' Earnings per Share (Diluted) too high?
Avant Brands' current Earnings per Share (Diluted) is C$-0.96. Based on the distribution chart, Avant Brands ranks #277 out of 786 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Avant Brands has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avant Brands' Earnings per Share (Diluted) compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Avant Brands ranks #277 out of 786 companies for Earnings per Share (Diluted). This puts Avant Brands in the upper half of its industry. The industry median Earnings per Share (Diluted) is 9.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Drug Manufacturers company?
The median Earnings per Share (Diluted) among Drug Manufacturers companies is 9.85, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Avant Brands and its competitors. For the Drug Manufacturers industry, the median Earnings per Share (Diluted) is 9.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avant Brands's current Earnings per Share (Diluted) is C$-0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avant Brands stock overvalued right now?
Based on GuruFocus' analysis, Avant Brands (TSX:AVNT) is currently considered Possible Value Trap. The stock's GF Value™ is C$0.95, compared to a current price of C$0.62 — trading 34.7% below its estimated fair value. The current Earnings per Share (Diluted) is C$-0.96. Avant Brands' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Avant Brands (TSX:AVNT), the current Earnings per Share (Diluted) is C$-0.96 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avant Brands (TSX:AVNT) Overvalued in 2026?
Based on GuruFocus' analysis, Avant Brands stock appears to be undervalued.
The current stock price of C$0.62 is trading 34.7% below its estimated GF Value™ of C$0.95.
GuruFocus considers Avant Brands to be Possible Value Trap.
Key valuation signals for TSX:AVNT:
Earnings per Share (Diluted): C$-0.96
GF Value™: C$0.95 vs. price of C$0.62 (34.7% below fair value)
No single metric tells the full story. See the TSX:AVNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avant Brands Inc operating in the cannabis industry, engages in the cultivation, production, marketing, and sale of cannabis products. Its product portfolio mainly consists of dried cannabis flower and related cannabis products, with the company managing the entire value chain from cultivation and harvesting to processing, packaging, and distribution, generating revenue upon delivery of products to customers. It operates in Canada.
31GF Score
Get the complete analysis for TSX:AVNT
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:AVNT has been successfully added to your 
